Chronic divalproex sodium to attenuate agitation and clinical progression of Alzheimer disease.
Tariot PN, Schneider LS, Cummings J, Thomas RG, Raman R, Jakimovich LJ, Loy R, Bartocci B, Fleisher A, Ismail MS, Porsteinsson A, Weiner M, Jack CR Jr, Thal L, Aisen PS; Alzheimer's Disease Cooperative Study Group.
Tariot PN, et al.
Arch Gen Psychiatry. 2011 Aug;68(8):853-61. doi: 10.1001/archgenpsychiatry.2011.72.
Arch Gen Psychiatry. 2011.
PMID: 21810649
Free PMC article.
Clinical Trial.